Indonesia vs Zambia: Treatment coverage for lymphatic filariasis
Indonesia
51.8%
in 2024
Zambia
37.0%
in 2021
Indonesia rank
41st
Zambia rank
44th
Treatment coverage for lymphatic filariasis over time
- Indonesia
- Zambia
How they compare
Indonesia currently reports 51.8% against 37.0% in Zambia, a difference of 14.8%.
That makes Indonesia's figure about 1.4 times Zambia's.
The two have swapped places 2 times across 9 shared years of data; in 2013 it was Indonesia ahead.
Indonesia ranks 41st and Zambia ranks 44th of 66 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 57.9% | 54.0% | 3.8% | Indonesia |
| 2020s | 69.9% | 43.9% | 26.0% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Indonesia or Zambia?
- Indonesia, at 51.8% against 37.0% in Zambia as of 2024.
- What is the difference in treatment coverage for lymphatic filariasis between Indonesia and Zambia?
- 14.8%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Zambia?
- 9 years are reported by both, from 2013 to 2021.
- How do Indonesia and Zambia rank globally for treatment coverage for lymphatic filariasis?
- Indonesia ranks 41st and Zambia ranks 44th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.